Paranasal sinuses and epithelial tumors
<Pics from Wikipedia, just for study>
1. Four sinuses:
-- Frontal
-- Ethmoid
-- Sphenoid (near optic nerve and CN3, 4, 5-1, 5-2, 6 , internal carotid artery)
-- Maxillary (Max. in size, most common tumor site among paranasal sinuses)
2. Tumor position and symptoms
--Inside nasal cavity (compared to paranasal sinuses)
->more symptoms at early stage( ex. epistaxis, nasal congestion)
3. Tumors at paranasal sinuses
-- Occupy only 3 % of head and neck malig.;
1% of all cancers;
diagnosed on elder people(60 y/o)
and chemical/wood dust-exposed workers,
smokers
-- Metastasis to: retropharygeal LN(right:No. 4), jugulodigastric LN(left:No. 9); both rare
4. Symptoms of paranasal sinus tumors
-- early : nasal congestions, epistaxis, facial pain
-- late: epiphora
facial edema
trimus, maloccusion
hearing loss
neck mass
proptosis
cranial nerve deficits( CNII, III, IV, V1, V2, VI)
5. Evaluation tools
-- MRI: nerves, soft tissues
-- CT: bones (thinner at first, thicker in later stages)
-- sinus lavage, FNA, transnasal biopsy: cell type, malig.?
6. Benign epithelial tumors
-- 3P1A (exophytic, inverted, columnar papilloma; adenoma)
Inverted papilloma:
<epi.> 0.2~0.6/100000 incidence; 50 y/o↑ white male; HPV 6, 11 related
<location>unilateral, multicentric at lateral wall
<macro> rough, vascularization↑
<micro> local invasion with intact basal membrane
<treat> high recurrence rate(10~30%), malig. change (5~20%)
suggest En bloc surgery via endoscope and F/U
7. Malig. epithelial tumors
SCC:
<epi.> 50-90% of malig. sinonasal tumor, 50~69y/o
<location> Maxillary sinus
<prog.> disease-free survival <50%
Adenoid cystic carcinoma:
<location> Maxillary sinus
<prog.> Perineural spread (50~76% recurrence)
Mucosal melanoma:
<epi.> 5th to 8th decade
<location> Nasal cavity
<macro> grey~black
<prog.> Early vascular and lymphatic invasion; median survival 15 months, five year survival 23%
Neuroendocrine=olfactory neuroblastoma
Esthesioneuroblastoma (ENB)
<epi.> most common NET; bimodal (10~20, 50~60y/o)frequency
<micro> locally aggressive
<prog.> local recurrence >10 y/o later, better prog.
<stage> Kadish/UCLA
Sinonasal neuroendocrine carcinoma (rare & rarely functional)
<epi.> more in 50 y/o males
<location> unknown origin
<prog.> 5 year survival 74~100%
<treat> curative: surgery
Sinonasal undifferentiated carcinoma (SNUC)
<micro> highly aggressive, local
<prog.> 1 year
<treat> OP+RT+CHEMO
<micro> dis. mets↑
--Inside nasal cavity (compared to paranasal sinuses)
->more symptoms at early stage( ex. epistaxis, nasal congestion)
3. Tumors at paranasal sinuses
-- Occupy only 3 % of head and neck malig.;
1% of all cancers;
diagnosed on elder people(60 y/o)
and chemical/wood dust-exposed workers,
smokers
-- Metastasis to: retropharygeal LN(right:No. 4), jugulodigastric LN(left:No. 9); both rare
4. Symptoms of paranasal sinus tumors
-- early : nasal congestions, epistaxis, facial pain
-- late: epiphora
facial edema
trimus, maloccusion
hearing loss
neck mass
proptosis
cranial nerve deficits( CNII, III, IV, V1, V2, VI)
5. Evaluation tools
-- MRI: nerves, soft tissues
-- CT: bones (thinner at first, thicker in later stages)
-- sinus lavage, FNA, transnasal biopsy: cell type, malig.?
6. Benign epithelial tumors
-- 3P1A (exophytic, inverted, columnar papilloma; adenoma)
Inverted papilloma:
<epi.> 0.2~0.6/100000 incidence; 50 y/o↑ white male; HPV 6, 11 related
<location>unilateral, multicentric at lateral wall
<macro> rough, vascularization↑
<micro> local invasion with intact basal membrane
<treat> high recurrence rate(10~30%), malig. change (5~20%)
suggest En bloc surgery via endoscope and F/U
7. Malig. epithelial tumors
SCC:
<epi.> 50-90% of malig. sinonasal tumor, 50~69y/o
<location> Maxillary sinus
<prog.> disease-free survival <50%
Adenocarcinoma:
<epi.> 2nd common malig. sinonasal tumor, hard-wood dust highly related
<location> Ethmoid sinus
<prog.> 1/3 meta in high grade
<epi.> 2nd common malig. sinonasal tumor, hard-wood dust highly related
<location> Ethmoid sinus
<prog.> 1/3 meta in high grade
Adenoid cystic carcinoma:
<location> Maxillary sinus
<prog.> Perineural spread (50~76% recurrence)
Mucosal melanoma:
<epi.> 5th to 8th decade
<location> Nasal cavity
<macro> grey~black
<prog.> Early vascular and lymphatic invasion; median survival 15 months, five year survival 23%
Neuroendocrine=olfactory neuroblastoma
Esthesioneuroblastoma (ENB)
<epi.> most common NET; bimodal (10~20, 50~60y/o)frequency
<micro> locally aggressive
<prog.> local recurrence >10 y/o later, better prog.
<stage> Kadish/UCLA
Sinonasal neuroendocrine carcinoma (rare & rarely functional)
<epi.> more in 50 y/o males
<location> unknown origin
<prog.> 5 year survival 74~100%
<treat> curative: surgery
Sinonasal undifferentiated carcinoma (SNUC)
<micro> highly aggressive, local
<prog.> 1 year
<treat> OP+RT+CHEMO
Sinonasal small cell (undifferentiated) carcinoma
<micro> dis. mets↑
沒有留言:
張貼留言